Taiwan’s SCI Journal JFDA Attains Impact Factor of 3.0 — Now Welcoming Citations and Global Research Contributions
【Update Date:2025-08-04】unit:企劃及科技管理組
The Journal of Food and Drug Analysis (JFDA), Taiwan’s only SCI (Science Citation Index)-listed international scientific journal in the fields of food and drug research, has achieved an Impact Factor (IF) of 3.0 according to the latest report released in June 2025. TFDA warmly invites experts, scholars, and professionals to cite, subscribe to, and submit research results to the journal.
JFDA is published online quarterly—in March, June, September, and December—through its dedicated journal website by Elsevier, a globally renowned academic publisher, under commission by the TFDA. The journal features English-language articles in the form of reviews, original research, case reports, and research notes, covering global research in food, pharmaceuticals, toxicology, medical devices, cosmetics, and related fields. According to the latest Journal Citation Reports (JCR), JFDA’s 2024 Impact Factor (IF) is 3.0, placing it in Q2 among SCI journals in both the food science category (88th out of 181 journals) and pharmaceutical science category (138th out of 352 journals). Among all SCI journals from Taiwan across all disciplines, JFDA ranks 8th out of 34.
As of June 2025, JFDA has published a total of 1,928 articles, with submissions originating from 106 countries worldwide. In 2024 alone, the journal’s articles were cited 5,429 times. Since the launch of its dedicated website, JFDA articles have been downloaded 718,101 times across 193 countries. In addition to publishing author-submitted content in each issue, JFDA actively follows current research developments and trends by inviting leading experts to contribute feature articles or guest-edit special issues on trending topics. Notable examples include the 2022 Special Issue on Analysis of Food Toxins: Challenges and Future Trends and the 2024 Special Issue on State-of-the-Art Nanomaterials Revolutionizing the Food and Pharmaceutical Sector, both of which highlight and lead research directions in key or emerging fields.
As of June 13, 2025, JFDA has published Volume 33, Issue 2. The journal features rich and internationally-relevant content, earning wide recognition and attention from professionals across various disciplines. JFDA continues to welcome submissions of high-quality research results from the global scientific community, and encourages readers to visit the official journal website to freely read, download, and cite published articles. (Submission System: https://www.editorialmanager.com/jfda/; Journal Website: https://www.jfda-online.com/journal/).